These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36922444)

  • 1. [Effects of lithium, valproic acid, carbamazepine and antipsychotic agents on cognition in bipolar disorders-A systematic review].
    Leopold S; Quante A
    Nervenarzt; 2023 May; 94(5):417-424. PubMed ID: 36922444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbamazepine treatment of bipolar disorder: a retrospective evaluation of naturalistic long-term outcomes.
    Chen CH; Lin SK
    BMC Psychiatry; 2012 May; 12():47. PubMed ID: 22620289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of adverse effects of mood stabilizers.
    Murru A; Popovic D; Pacchiarotti I; Hidalgo D; León-Caballero J; Vieta E
    Curr Psychiatry Rep; 2015 Aug; 17(8):603. PubMed ID: 26084665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The influence of mood-normalizing agents on cognitive functions].
    Suwalska A; Łojko D; Rybakowski J
    Psychiatr Pol; 2001; 35(2):245-56. PubMed ID: 11490889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic evidence for manic episode].
    Terao T
    Seishin Shinkeigaku Zasshi; 2011; 113(9):867-72. PubMed ID: 22117391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Algorithms for bipolar mania.
    Post RM; Denicoff KD; Frye MA; Leverich GS
    Mod Probl Pharmacopsychiatry; 1997; 25():114-45. PubMed ID: 9344373
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis.
    Liu HY; Potter MP; Woodworth KY; Yorks DM; Petty CR; Wozniak JR; Faraone SV; Biederman J
    J Am Acad Child Adolesc Psychiatry; 2011 Aug; 50(8):749-62.e39. PubMed ID: 21784295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of response to mood stabilizers.
    Calabrese JR; Fatemi SH; Kujawa M; Woyshville MJ
    J Clin Psychopharmacol; 1996 Apr; 16(2 Suppl 1):24S-31S. PubMed ID: 8707997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Algorithms for the pharmacotherapy of bipolar disorder.
    Motohashi N
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S41-4. PubMed ID: 10560897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing changes for bipolar patients discharged from two public psychiatric hospitals in Taiwan, 2006-2019.
    Lin CH; Chan HY; Chen CC; Chou FH
    J Affect Disord; 2022 Dec; 318():386-392. PubMed ID: 36103936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic drugs, mood stabilizers, and risk of pneumonia in bipolar disorder: a nationwide case-control study.
    Yang SY; Liao YT; Liu HC; Chen WJ; Chen CC; Kuo CJ
    J Clin Psychiatry; 2013 Jan; 74(1):e79-86. PubMed ID: 23419234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Are mood stabilizers beneficial in the treatment of schizophrenia?].
    Berle JØ; Spigset O
    Tidsskr Nor Laegeforen; 2005 Jun; 125(13):1809-12. PubMed ID: 16012547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of valproate and lithium on dementia onset risk in bipolar disorder patients.
    Moon W; Ji E; Shin J; Kwon JS; Kim KW
    Sci Rep; 2022 Aug; 12(1):14142. PubMed ID: 35986042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
    Dunner DL
    J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome in the pharmacologic treatment of bipolar disorder.
    Keck PE; McElroy SL
    J Clin Psychopharmacol; 1996 Apr; 16(2 Suppl 1):15S-23S. PubMed ID: 8707996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between use of mood stabilizers and risk of cataract: A population-based nested case-control study.
    Chu CS; Lin CH; Lan TH; Chou PH
    J Affect Disord; 2018 Feb; 227():79-81. PubMed ID: 29053979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: A systematic review.
    van den Ameele S; van Diermen L; Staels W; Coppens V; Dumont G; Sabbe B; Morrens M
    J Affect Disord; 2016 Oct; 203():364-373. PubMed ID: 27344047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
    Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
    Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.